Vaccination in Patients with Liver Cirrhosis: A Neglected Topic

Area of Science:

• Immunology
• Hepatology
• Public Health

Background:

• Patients with liver cirrhosis exhibit compromised innate and adaptive immunity, increasing susceptibility to infections.
• Impaired immune function in cirrhosis leads to a diminished antibody response following vaccination.
• Despite suboptimal responses, vaccinations are recommended by major liver societies (AASLD, EASL) to mitigate severe outcomes and mortality.

Purpose of the Study:

• To highlight the importance of vaccination in liver cirrhosis patients.
• To address the issue of suboptimal vaccine coverage in this vulnerable population.
• To recommend strategies for improving vaccine uptake and efficacy.

Main Methods:

• Review of current literature and guidelines on vaccination in liver disease.
• Analysis of factors contributing to low vaccine coverage in cirrhotic patients.
• Synthesis of recommendations for enhancing vaccine effectiveness and accessibility.

Main Results:

• Vaccines are effective in reducing severe outcomes and deaths in cirrhotic patients, even with a limited antibody response.
• Vaccine coverage remains suboptimal despite strong recommendations from liver societies.
• Early vaccination in chronic liver disease is associated with higher efficacy.

Conclusions:

• Vaccination is essential for liver cirrhosis patients to prevent severe infections and mortality.
• Strategies including improved patient counseling, combating misinformation, and removing access barriers are needed to increase vaccine coverage.
• Timely administration of vaccines early in the course of chronic liver disease is critical for maximizing benefits.